These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21116779)

  • 41. Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout.
    Bruce SP
    Ann Pharmacother; 2006 Dec; 40(12):2187-94. PubMed ID: 17132810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved biological properties and hypouricemic effects of uricase from Candida utilis loaded in novel alkaline enzymosomes.
    Tan QY; Zhang JQ; Wang N; Yang H; Li X; Xiong HR; Wu JY; Zhao CJ; Wang H; Yin HF
    Int J Nanomedicine; 2012; 7():3929-38. PubMed ID: 22915844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.
    Sánchez-Lozada LG; Tapia E; Soto V; Avila-Casado C; Franco M; Zhao L; Johnson RJ
    Nephrol Dial Transplant; 2008 Apr; 23(4):1179-85. PubMed ID: 18048425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lonicera hypoglauca inhibits xanthine oxidase and reduces serum uric acid in mice.
    Chien SC; Yang CW; Tseng YH; Tsay HS; Kuo YH; Wang SY
    Planta Med; 2009 Mar; 75(4):302-6. PubMed ID: 19184967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Construction and expression of recombinant uricase‑expressing genetically engineered bacteria and its application in rat model of hyperuricemia.
    Cai L; Li Q; Deng Y; Liu X; Du W; Jiang X
    Int J Mol Med; 2020 May; 45(5):1488-1500. PubMed ID: 32323736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-Based Immunogenicity Prediction of Uricase from Fungal (Aspergillus flavus), Bacterial (Bacillus subtillis) and Mammalian Sources Using Immunoinformatic Approach.
    Tripathi S; Parmar J; Kumar A
    Protein J; 2020 Apr; 39(2):133-144. PubMed ID: 32221804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioengineered robust hybrid hydrogels enrich the stability and efficacy of biological drugs.
    Gil MS; Cho J; Thambi T; Giang Phan VH; Kwon I; Lee DS
    J Control Release; 2017 Dec; 267():119-132. PubMed ID: 28412223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uricase and Horseradish Peroxidase Hybrid CaHPO₄ Nanoflower Integrated with Transcutaneous Patches for Treatment of Hyperuricemia.
    Hao Y; Li H; Cao Y; Chen Y; Lei M; Zhang T; Xiao Y; Chu B; Qian Z
    J Biomed Nanotechnol; 2019 May; 15(5):951-965. PubMed ID: 30890227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of enzymatic uricolysis in the treatment of hyperuricemia of renal origin].
    Brogard JM; Frankhauser J; Stahl A
    Schweiz Med Wochenschr; 1973 Mar; 103(11):404-10. PubMed ID: 4691800
    [No Abstract]   [Full Text] [Related]  

  • 50. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
    Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
    N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The methanol extract of Euonymus laxiflorus, Rubia lanceolata and Gardenia jasminoides inhibits xanthine oxidase and reduce serum uric acid level in rats.
    Liu LM; Cheng SF; Shieh PC; Lee JC; Chen JJ; Ho CT; Kuo SC; Kuo DH; Huang LJ; Way TD
    Food Chem Toxicol; 2014 Aug; 70():179-84. PubMed ID: 24845958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y
    Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacology of drugs for hyperuricemia. Mechanisms, kinetics and interactions.
    Pea F
    Contrib Nephrol; 2005; 147():35-46. PubMed ID: 15604604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flavonoids of Cynara scolymus possess potent xanthinoxidase inhibitory activity in vitro but are devoid of hypouricemic effects in rats after oral application.
    Sarawek S; Feistel B; Pischel I; Butterweck V
    Planta Med; 2008 Feb; 74(3):221-7. PubMed ID: 18300193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.
    Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Palo WA; Eustace D; Vernillet L; Joseph-Ridge N
    Arthritis Rheum; 2005 Mar; 52(3):916-23. PubMed ID: 15751090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits.
    B-Rao C; Kulkarni-Almeida A; Katkar KV; Khanna S; Ghosh U; Keche A; Shah P; Srivastava A; Korde V; Nemmani KV; Deshmukh NJ; Dixit A; Brahma MK; Bahirat U; Doshi L; Sharma R; Sivaramakrishnan H
    Bioorg Med Chem; 2012 May; 20(9):2930-9. PubMed ID: 22483591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral Delivery of Nanoparticles Carrying Ancestral Uricase Enzyme Protects against Hyperuricemia in Knockout Mice.
    Tran L; Das S; Zhao L; Finn MG; Gaucher EA
    Biomacromolecules; 2023 May; 24(5):2003-2008. PubMed ID: 37126604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phytochemicals from Acacia confusa heartwood extracts reduce serum uric acid levels in oxonate-induced mice: their potential use as xanthine oxidase inhibitors.
    Tung YT; Hsu CA; Chen CS; Yang SC; Huang CC; Chang ST
    J Agric Food Chem; 2010 Sep; 58(18):9936-41. PubMed ID: 20806936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral Treatment With an Engineered Uricase, ALLN-346, Reduces Hyperuricemia, and Uricosuria in Urate Oxidase-Deficient Mice.
    Pierzynowska K; Deshpande A; Mosiichuk N; Terkeltaub R; Szczurek P; Salido E; Pierzynowski S; Grujic D
    Front Med (Lausanne); 2020; 7():569215. PubMed ID: 33330529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.